UNCY - Unicycive Therapeutics GAAP EPS of -$0.24 August, 16 2022 03:12 AM Unicycive Therapeutics Inc. Unicycive Therapeutics press release ( NASDAQ: UNCY ): Q2 GAAP EPS of -$0.24. As June 30, 2022, cash and cash equivalents totaled $10.6M. For further details see: Unicycive Therapeutics GAAP EPS of -$0.24